Head-to-head · WeighScore
Allara Health vs FMmeds
The verdict
Allara Health takes it — 71.2/100 to 63.2/100.
Allara Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Allara Health (allarahealth.com) is an insurance-accepting telehealth platform focused on women's metabolic and hormonal health, including PCOS, serving 44 states plus DC.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Allara Health | FMmeds |
|---|---|---|
| WeighScore | 71.2/100 | 63.2/100 |
| Grade | C | C |
| Scorecard rank | #96 | #260 |
| Semaglutide | $149/mo (plus a separate fee, brand-name) | $225/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | $265/mo (all doses, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #96 · C
Strengths
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound)
- Accepts insurance with self-pay option from $149/month
- Women's-health and PCOS specialization with hormonal/metabolic testing
- Board-certified physicians, OB-GYNs, endocrinologists, plus dietitians
- Oral alternatives (Metformin, Contrave, Topiramate) available
Where it loses points
- Membership covers visits; GLP-1 medication coverage depends on your plan
- Not available in all states for medical care
- Focused on women's health, not a general GLP-1 provider
- Out-of-pocket branded GLP-1 cost can be high if not insurance-covered
Graded #260 · C
Strengths
- All 50 states plus DC covered, stated in the Terms
- Operating LLC and full Manhattan Beach, CA address disclosed
- Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
- Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
- Flat pricing across all dose strengths — no dose-escalation surcharge
Where it loses points
- Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
- Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
- Clinical network not separately named
- LegitScript Certified, but the specific ID isn't shown
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.